Assemblyman Fred W. Thiele Jr. (I, D, WF-Sag Harbor) announced the Assembly passed a series of bills – which have the support of the Senate and the governor – to improve the treatment and prevention of heroin and opioid addiction, which has reached epidemic levels in New York and throughout the nation. The legislation builds on previous efforts by the Assembly, which included $189 million in this year’s state budget for treatment and prevention initiatives as well as safe drug-disposal programs.

“Heroin addiction is ravaging communities across the state, and it’s clear that we need to take action now in order to save lives,” said Assemblyman Thiele. “These new laws will limit initial painkiller prescriptions and ensure people can get the treatment they need to beat addiction.”

The legislation takes steps to combat the heroin crisis by educating doctors as well as individuals who are prescribed opioids to, among other things, advise them of the risks of addiction, and preventing the risk for misuse by limiting the amount of opioids prescribed and further requiring coverage for inpatient care (A.10727).

The measures will:

• mandate three hours of education on pain management and palliative care for prescribers to be completed tri-annually;
• require insurance companies to provide coverage for a minimum of 14 days of inpatient treatment without prior authorization;
• set a seven-day limit on a patient’s first prescription of opioid medication for acute pain; and
• require pharmacists to provide consumers with educational materials regarding the dangers of addiction, availability of treatment and prescription disposal options when they are dispensing a controlled substance.

The legislation also expands access to addiction treatment. One measure increases the maximum time an individual incapacitated by drugs or alcohol can be brought to a treatment facility for detoxification services from 48 to 72 hours and requires those facilities to provide specific information in their discharge planning to help ensure individuals are connected with treatment after they detox (A.10725). It also requires insurers to provide five days of coverage for withdrawal treatment and eliminates the need for prior authorization by managed care companies for buprenorphine and Vivitrol ¬– drugs used to treat opioid dependence.

In addition, the Office of Alcoholism and Substance Abuse Services (OASAS) will extend the heroin and opioid addiction wraparound services program for an additional two years and identify best practices for these services. OASAS will also ensure that all utilization review tools used by insurers and providers are consistent with OASAS-defined treatment service levels to help improve substance use disorder treatment and coverage.

Another piece of legislation will allow social workers and certain other licensed professionals to administer Narcan – a drug which counteracts an opioid overdose – in an emergency (A.10726). It would also require the state to issue quarterly reports on overdoses and Narcan use, on a county-by-county basis, and require hospitals to implement discharge planning for patients who have – or are at risk for – a substance use disorder.

“It’s crucial to have a treatment plan in place for someone who is admitted to the hospital for an overdose so that we can get them on the path to recovery,” said Thiele. “We cannot continue to discharge patients who clearly have a substance abuse disorder without providing for further treatment. This plan will ensure those who are struggling with addiction can get the support they need.”